Cannabis Science, Inc. announced plans for international observational studies and research in 2014. Plans announced by the company to launch an observational clinical research study in 2014 will focus on patient driven use of cannabis and cannabis based products and the clinical outcomes of such use for a variety of medical conditions. The company will seek additional funding partners as well as academic and clinical collaborators for this project.

The company has been continuously conducting research into on cannabis and cannabinoids and in 2013 has also filed an application of a cannabinoid based patent and believes there is an enormous potential for the extension of its portfolio and filing of further patents. The direction of Cannabis Science is supported by Dr. Sanjay Gupta's reversing his original position on cannabis from believing that it was harmful to supporting the use of medical cannabis.